Nose Spray Vaccines Could Quash COVID Virus Variants
Three nasal spritzes, now in advanced trials, could trigger stronger immunity than shots in the arm
Related Articles
Bird flu will be the next pandemic unless health officials take 6 critical steps, experts say
The time for urgency, the experts say, is now.
Bird flu will be the next pandemic unless health officials take 6 critical steps, experts say
The time for urgency, the experts say, is now.
終わらないコロナ ～後遺症と闘う18歳～
[放送日時] 12月28日（土）ごぜん9:30～岡谷市在住の山田幸奈さん（18）は、2年前に新型コロナに感染。ほどなく陰性になったものの、全身が動かなくなり、寝たきりとなった。その後、都内の専門医に新型コロナ後遺症と診断される。後遺症の症状は200種類以上あると言われるが、倦怠感や気分の落ち込みが主症状であるため…
Long COVID and Other Post-Acute Infection Syndromes | Keystone Symposia
Join us at the Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes, August 2025, in Santa Fe, with field leaders!
Science In Action – 5 Years of Covid (part 1/2) – BBC Sounds
Five years on from the emergence of Sars CoV-2, what have we learned?
Revolutionizing Medicine Through Lymphatic Biology: The Story of Rho Bio | Yale Ventures
For decades, the lymphatic vascular system—a critical network that drains cellular waste and maintains immune balance—has been overlooked in biomedical research. Enter Rho Bio, a…
A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses
Profiling of ERV-reactive B-1 cells in mice reveals natural antibodies against terminal N-acetylglucosamine on multiple viral envelope proteins.
Hirschhausen und der lange Schatten von Corona – hier anschauen
Corona hat Spuren hinterlassen, Leben verändert – und hunderttausende Menschen dauerhaft krank gemacht. Deutschlands bekanntester Arzt, Eckart von Hirschhausen, begleitet einige der Betroffenen seit Jahren.…
A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses
Profiling of ERV-reactive B-1 cells in mice reveals natural antibodies against terminal N-acetylglucosamine on multiple viral envelope proteins.
Antibodies that keep ancient viral DNA in check may inform new
B-1 immune cells can recognize all sorts of viruses, Yale researchers find. Mimicking them may enable a pan-virus treatment that can address many virus types.